Bright Minds Biosciences (NASDAQ: DRUG) Soars 1800% Amid Short Squeeze Alongside PRSO, ILLR and NIVF

The biotech world is buzzing as Bright Minds Biosciences (NASDAQ: DRUG) exploded yesterday with a +1500% surge, rocketing from $2.47 to $38.35 during regular trading, and hitting $50 in after-hours trading-marking a total rise of 1800% in a single day. With its market cap soaring from $4 million to $172 million, this dramatic short squeeze has caught the attention of investors everywhere. Bright Minds, a cutting-edge biotechnology company, is pioneering treatments for neurological and psychiatric disorders, including epilepsy and depression, with its innovative pipeline of selective serotonergic agonists aimed at transforming patient care. DRUG was featured in our pre-market spotlight on 10/15/2024 at just $2.47 per share see more. [https://thestreetreports.com/?p=4244]

Similarly, Peraso Inc. (NASDAQ: PRSO), a leader in mmWave wireless technology, is gaining traction as it prepares to showcase the strategic advantages of its 60 GHz mmWave technology for military and defense applications. With a focus on beamforming and phased array antenna technologies, Peraso's solutions are poised to meet the growing demand for secure, high-speed communication in the defense sector.

Meanwhile, AGBA Group Holding Ltd. (Nasdaq: AGBA) has completed its merger with Triller Corp., rebranding as Triller Group Inc. The combined company's stock will start trading under the ticker "ILLR" on October 16, 2024, offering exciting new opportunities for content creators and fans of BKFC and TrillerTV to engage with the innovative platform.

In another key sector, NewGenIvf Group Limited (NASDAQ: NIVF) continues to make waves in the fertility industry across Asia, offering comprehensive services such as assisted reproductive technologies, egg and sperm donation, and surrogacy in appropriate jurisdictions. With clinics in Thailand, Cambodia, and Kyrgyzstan, NewGen is helping couples and individuals overcome fertility challenges and build families.

These companies-DRUG, PRSO, AGBA, and NIVF-demonstrate strong market movements and hold immense potential in their respective industries, making them ones to watch today and in the coming days.

Disclaimers: The Private Securities Litigation Reform Act of 1995 provides investors with a safe harbor with regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, assumptions, objectives, goals, and assumptions about future events or performance are not statements of historical fact and may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements, indicating certain actions & quotes; may, could or might occur Understand there is no guarantee past performance is indicative of future results. Investing in micro-cap or growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor's investment may be lost or due to the speculative nature of the companies profiled. TheStreetReports (TSR) is responsible for the production and distribution of this content."TSR" is not operated by a licensed broker, a dealer, or a registered investment advisor. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. "TSR" authors, contributors, or its agents, may be compensated for preparing research, video graphics, podcasts and editorial content. "TSR" has not been compensated to produce content related to "Any Companies" appearing herein. As part of that content, readers, subscribers, and everyone viewing this content are expected to read the full disclaimer in our website.

Media Contact
Company Name: The Street Reports
Contact Person: Editor
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=bright-minds-biosciences-nasdaq-drug-soars-1800-amid-short-squeeze-alongside-prso-illr-and-nivf]
Country: United States
Website: http://www.thestreetreports.com



This release was published on openPR.